Ischemic heart disease still represents a large burden on individuals and health care
resources worldwide. By conventions, it is equated with atherosclerotic plaque due to flow …

Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

When implemented in practice, digital technologies have shown improvements in morbidity
and mortality outcomes in patients with cardiovascular disease (CVD). For scholars …

It is unclear to what extent the COVID-19 pandemic has influenced the use of remote
monitoring (RM) of cardiac implantable electronic devices (CIEDs). The present physician …

Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID‐19) is a huge
determinant of prognosis during the acute phase of the disease. However, little is known …

The clinical manifestations of COVID-19 are widely variable and may involve several
districts. Although the clinical course is mostly characterized by respiratory involvement, up …

Background: Heart failure (HF) patients are predisposed to recurrences and disease
destabilizations, especially during the COVID-19 outbreak period. In this scenario …

Background: The unexpected emergence of coronavirus disease 2019 (COVID-19) has
changed mindsets about the healthcare system and medical practice in many fields, forcing …

Heart failure with preserved ejection fraction (HFpEF) is a complex clinical syndrome
responsible for high mortality and morbidity rates. It has an ever growing social and …

Introduction The onset of COVID-19 has caused an international upheaval of traditional in-
person approaches to care delivery. Rapid system-level transitions to virtual care provision …